Trans-4-amino(alkyl)-1-pyridylcarbamoylcyclohexane compounds and pharmaceutical use thereof
    1.
    发明公开
    Trans-4-amino(alkyl)-1-pyridylcarbamoylcyclohexane compounds and pharmaceutical use thereof 失效
    反式-4-氨基(烷基)-1-吡啶基氨基甲酰基环己烷 - 维生素A和苯并呋喃酮。

    公开(公告)号:EP0370498A2

    公开(公告)日:1990-05-30

    申请号:EP89121587.3

    申请日:1989-11-22

    摘要: A trans-4-amino(alkyl)-1-pyridylcarbamoylcyclohexane compound of the formula:
    wherein R¹ and R² are the same or different, and respectively represent hydrogen, C₁₋₁₀ alkyl, C₂₋₅ alkanoyl, formyl, C₁₋₄ alkoxy-carbonyl, amidino, C₃₋₇ cycloalkyl, C₃₋₇ cycloalkyl­carbonyl, phenyl, phenylalkyl, benzoyl, naphthoyl, phenylalkoxy­carbonyl, benzylidene, pyridylcarbonyl, piperidyl, pyrroli­dylidene or piperidylidene which may be optionally substituted on the ring or R¹ and R² together with the adjacent nitrogen atom form 5 to 6-membered cycle which may have oxygen atom, sulfur atom or optionally substituted nitrogen atom in the cycle, or together with the adjacent nitrogen atom form phthalimido, R³ represents hydrogen or C₁₋₄ alkyl, R⁴ represents hydrogen or C₁₋₄ alkyl, R⁵ represents hydrogen, hydroxyl C₁₋₄ alkyl or phenylalkoxy. R⁶ represents hydrogen or C₁₋₄ alkyl, A represents single bond, C₁₋₅ straight chain alkylene, or alkylene which is substituted by C₁₋₄ alkyl, n represents 0 to 1, an optical isomer thereof and a pharmaceutically acceptable acid addition salt thereof.
    These compounds possess antihypertensive activity, and coronary, cerebral and kidney circulation-improving activities and are useful as antihypertensive agents and agents for prevention and treatment of circulatory diseases.

    摘要翻译: 下式的反式-4-氨基(烷基)-1-吡啶基氨基甲酰基环己烷化合物:其中R 1和R 2相同或不同,分别表示氢,C 1-10烷基,C 2-5 烷酰基,甲酰基,C 1-4烷氧基 - 羰基,脒基,C 3-7环烷基,C 3-7环烷基羰基,苯基,苯基烷基,苯甲酰基,萘甲酰基,苯基烷氧基羰基,亚苄基,吡啶基羰基,哌啶基,吡咯烷亚基或哌啶基, 或R 1和R 2与相邻的氮原子一起形成5至6元环,其可在该循环中具有氧原子,硫原子或任选取代的氮原子,或与相邻的氮原子一起形成苯二甲酰亚氨基, R 3表示氢或C 1-4烷基,R 4表示氢或C 1-4烷基,R 5表示氢,羟基C 1-4烷基或苯基烷氧基。 R 6表示氢或C 1-4烷基,A表示单键,C 1-5直链亚烷基或被C 1-4烷基取代的亚烷基,n表示0至1,其旋光异构体和药学上可接受的酸 加成盐。 这些化合物具有抗高血压活性和冠心病,脑和肾循环改善活性,可用作抗高血压药和预防和治疗循环系统疾病的药剂。

    PAF-antagonistic thienotriazolodiazepine compounds and pharmaceutical uses thereof
    2.
    发明公开
    PAF-antagonistic thienotriazolodiazepine compounds and pharmaceutical uses thereof 失效
    PAF拮抗剂Thienotriazoldiazepin-Verbindungen und deren pharmazeutische Anwendung。

    公开(公告)号:EP0268242A1

    公开(公告)日:1988-05-25

    申请号:EP87116880.3

    申请日:1987-11-16

    IPC分类号: C07D495/14 A61K31/55

    CPC分类号: C07D495/14

    摘要: A thienotriazolodiazepine compound of the general formula (I):
    wherein each symbol is as defined in the specification and a pharmaceutically acceptable acid addition salt thereof, and pharmaceutical uses thereof.
    Said compounds exhibit PAF-antagonistic activity and are useful for the prevention or treatment of various PAF-induced diseases.

    摘要翻译: 通式(I)的噻吩并三氮杂环素类化合物:其中各符号如说明书中所定义,及其药学上可接受的酸加成盐及其药学用途。 所述化合物表现出PAF拮抗活性,并且可用于预防或治疗各种PAF诱导的疾病。

    Trans-4-amino(alkyl)-1-pyridylcarbamoylcyclohexane compounds and pharmaceutical use thereof
    4.
    发明公开
    Trans-4-amino(alkyl)-1-pyridylcarbamoylcyclohexane compounds and pharmaceutical use thereof 失效
    TRANS-4-氨基(烷基)-1-吡啶基甲酰基胆碱化合物及其药物用途

    公开(公告)号:EP0370498A3

    公开(公告)日:1991-05-08

    申请号:EP89121587.3

    申请日:1989-11-22

    摘要: A trans-4-amino(alkyl)-1-pyridylcarbamoylcyclohexane compound of the formula:
    wherein R¹ and R² are the same or different, and respectively represent hydrogen, C₁₋₁₀ alkyl, C₂₋₅ alkanoyl, formyl, C₁₋₄ alkoxy-carbonyl, amidino, C₃₋₇ cycloalkyl, C₃₋₇ cycloalkyl­carbonyl, phenyl, phenylalkyl, benzoyl, naphthoyl, phenylalkoxy­carbonyl, benzylidene, pyridylcarbonyl, piperidyl, pyrroli­dylidene or piperidylidene which may be optionally substituted on the ring or R¹ and R² together with the adjacent nitrogen atom form 5 to 6-membered cycle which may have oxygen atom, sulfur atom or optionally substituted nitrogen atom in the cycle, or together with the adjacent nitrogen atom form phthalimido, R³ represents hydrogen or C₁₋₄ alkyl, R⁴ represents hydrogen or C₁₋₄ alkyl, R⁵ represents hydrogen, hydroxyl C₁₋₄ alkyl or phenylalkoxy. R⁶ represents hydrogen or C₁₋₄ alkyl, A represents single bond, C₁₋₅ straight chain alkylene, or alkylene which is substituted by C₁₋₄ alkyl, n represents 0 to 1, an optical isomer thereof and a pharmaceutically acceptable acid addition salt thereof. These compounds possess antihypertensive activity, and coronary, cerebral and kidney circulation-improving activities and are useful as antihypertensive agents and agents for prevention and treatment of circulatory diseases.